Exelixis Pharmaceuticals, Inc.
Records under this name other than patents Exelixis Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Exelixis Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,531,644 | Methods for identifying anti-cancer drug targets Term ended Term ended Jan 20, 2020 · USPTO record | Term ended | Term ended Jan 20, 2020 | USPTO record |
| US 6,511,824 | Nucleic acids and polypeptides of invertebrate TWIK channels and methods of use Term ended Term ended Mar 17, 2019 · USPTO record | Term ended | Term ended Mar 17, 2019 | USPTO record |
| US 6,468,770 | Nucleic acids and proteins of D. melanogaster insulin-like genes and uses thereof Term ended Term ended Nov 30, 2018 · USPTO record | Term ended | Term ended Nov 30, 2018 | USPTO record |
| US 7,125,687 | Presenilin enhancers assays Lapsed on the fee record Ended Oct 24, 2018 · USPTO record | Lapsed on the fee record | Ended Oct 24, 2018 | USPTO record |
| US 6,218,526 | Polynucleotide encoding human netrin-1 Term ended Term ended Aug 20, 2018 · USPTO record | Term ended | Term ended Aug 20, 2018 | USPTO record |
| US 6,225,285 | Semaphorin K1 Term ended Term ended Mar 11, 2018 · USPTO record | Term ended | Term ended Mar 11, 2018 | USPTO record |
| US 6,781,028 | Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism Lapsed on the fee record Ended Aug 24, 2016 · USPTO record | Lapsed on the fee record | Ended Aug 24, 2016 | USPTO record |
| US 6,703,491 | Drosophila sequences Formerly held Lapsed on the fee record Ended Mar 9, 2016 · USPTO record | Lapsed on the fee record | Ended Mar 9, 2016 | USPTO record |
| US 6,627,746 | Nucleic acids and proteins of C. elegans insulin-like genes and uses thereof Formerly held Lapsed on the fee record Ended Sep 30, 2015 · USPTO record | Lapsed on the fee record | Ended Sep 30, 2015 | USPTO record |
| US 6,583,277 | Semaphorin K1 Lapsed on the fee record Ended Jun 24, 2015 · Medium confidence | Lapsed on the fee record | Ended Jun 24, 2015 | Medium confidence |